Prostate-specific antigen and long-term prediction of prostate cancer incidence and mortality in the general population

Research output: Contribution to journal › Journal article › Research › peer-review

Presentation
Citation formats

David D Orsted
Nordestgaard, Børge
Gorm B Jensen
Peter Schnohr
Bojesen, Stig Egil
David Dynnes Ørsted

It is largely unknown whether prostate-specific antigen (PSA) level at first date of testing predicts long-term risk of prostate cancer (PCa) incidence and mortality in the general population.

Original language	English
Journal	European Urology
Volume	61
Issue number	5
Pages (from-to)	865-74
Number of pages	10
ISSN	0302-2838
DOIs	https://doi.org/10.1016/j.eururo.2011.11.007
Publication status	Published - 2012

ID: 40162974